AZN vs. BARC.L
AZN (AstraZeneca PLC) and BARC.L (Barclays plc) are both stocks. AZN operates in Drug Manufacturers - General (Healthcare), while BARC.L operates in Banks - Diversified (Financial Services). Over the past 10 years, AZN returned 15.85%/yr vs 12.03%/yr for BARC.L. At a 0.25 correlation, their price movements are largely independent.
Performance
AZN vs. BARC.L - Performance Comparison
Loading charts...
Different Trading Currencies
AZN is traded in USD, while BARC.L is traded in GBp. To make them comparable, the BARC.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, AZN achieves a 0.81% return, which is significantly higher than BARC.L's -3.93% return. Over the past 10 years, AZN has outperformed BARC.L with an annualized return of 15.85%, while BARC.L has yielded a comparatively lower 12.03% annualized return.
AZN
- 1D
- -2.37%
- 1M
- -0.71%
- YTD
- 0.81%
- 6M
- 1.53%
- 1Y
- 28.04%
- 3Y*
- 9.54%
- 5Y*
- 12.08%
- 10Y*
- 15.85%
BARC.L
- 1D
- -0.31%
- 1M
- 2.59%
- YTD
- -3.93%
- 6M
- 5.69%
- 1Y
- 37.66%
- 3Y*
- 49.87%
- 5Y*
- 22.43%
- 10Y*
- 12.03%
AZN vs. BARC.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | 0.81% | 43.30% | -0.62% | 1.44% | 19.14% | 19.66% | 3.12% | 35.68% | 13.86% | 33.10% |
BARC.L Barclays plc | -3.93% | 95.96% | 77.29% | 5.80% | -22.23% | 28.13% | -15.85% | 28.33% | -28.91% | 0.54% |
Correlation
The correlation between AZN and BARC.L is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Jul 5, 2007 | 0.25 |
The correlation between AZN and BARC.L shifts across timeframes, from 0.13 (10 years) to 0.25 (all time), reflecting how their relationship changes across market environments.
Fundamentals
AZN:
$283.40B
BARC.L:
£62.60B
AZN:
$6.66
BARC.L:
£0.52
AZN:
27.27
BARC.L:
8.78
AZN:
0.04
BARC.L:
1.45
AZN:
4.69
BARC.L:
1.56
AZN:
5.99
BARC.L:
0.82
AZN:
$60.44B
BARC.L:
£40.71B
AZN:
$49.37B
BARC.L:
£40.18B
AZN:
$20.47B
BARC.L:
£9.83B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AZN vs. BARC.L — Risk / Return Rank
AZN
BARC.L
AZN vs. BARC.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AstraZeneca PLC (AZN) and Barclays plc (BARC.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AZN | BARC.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.09 | ||
| Sortino ratioReturn per unit of downside risk | +0.08 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.22 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 1.83 | 1.41 | +0.42 |
| Martin ratioReturn relative to average drawdown | 4.90 | 4.10 | +0.80 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AZN | BARC.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.11 | 1.20 | -0.09 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.51 | 0.67 | -0.16 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.64 | 0.32 | +0.32 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.49 | -0.02 | +0.51 |
Drawdowns
AZN vs. BARC.L - Drawdown Comparison
The maximum AZN drawdown since its inception was -48.94%, smaller than the maximum BARC.L drawdown of -94.50%. Use the drawdown chart below to compare losses from any high point for AZN and BARC.L.
Loading charts...
Drawdown Indicators
| AZN | BARC.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.94% | -94.50% | +45.56% |
Max Drawdown (1Y)Largest decline over 1 year | -15.43% | -26.54% | +11.11% |
Max Drawdown (3Y)Largest decline over 3 years | -27.87% | -26.54% | -1.33% |
Max Drawdown (5Y)Largest decline over 5 years | -27.87% | -48.02% | +20.15% |
Max Drawdown (10Y)Largest decline over 10 years | -27.87% | -67.33% | +39.46% |
Current DrawdownCurrent decline from peak | -12.90% | -20.57% | +7.67% |
Average DrawdownAverage peak-to-trough decline | -11.37% | -65.29% | +53.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.75% | 9.14% | -3.39% |
Volatility
AZN vs. BARC.L - Volatility Comparison
The current volatility for AstraZeneca PLC (AZN) is 7.42%, while Barclays plc (BARC.L) has a volatility of 9.34%. This indicates that AZN experiences smaller price fluctuations and is considered to be less risky than BARC.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AZN | BARC.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.42% | 9.34% | -1.92% |
Volatility (6M)Calculated over the trailing 6-month period | 17.47% | 24.99% | -7.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.55% | 31.25% | -5.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.02% | 33.71% | -9.69% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.94% | 37.50% | -12.56% |
Dividends
AZN vs. BARC.L - Dividend Comparison
AZN's dividend yield for the trailing twelve months is around 2.93%, more than BARC.L's 1.89% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | 2.93% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
BARC.L Barclays plc | 1.89% | 1.79% | 2.28% | 3.73% | 2.93% | 1.33% | 0.00% | 2.90% | 2.22% | 1.10% | 1.50% | 2.21% |
Financials
AZN vs. BARC.L - Financials Comparison
This section allows you to compare key financial metrics between AstraZeneca PLC and Barclays plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AZN vs. BARC.L - Profitability Comparison
AZN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a gross profit of 12.61B and revenue of 15.29B. Therefore, the gross margin over that period was 82.5%.
BARC.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Barclays plc reported a gross profit of 8.16B and revenue of 8.16B. Therefore, the gross margin over that period was 100.0%.
AZN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported an operating income of 4.25B and revenue of 15.29B, resulting in an operating margin of 27.8%.
BARC.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Barclays plc reported an operating income of 2.81B and revenue of 8.16B, resulting in an operating margin of 34.5%.
AZN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a net income of 3.08B and revenue of 15.29B, resulting in a net margin of 20.2%.
BARC.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Barclays plc reported a net income of 2.18B and revenue of 8.16B, resulting in a net margin of 26.7%.
Frequently Asked Questions
AZN and BARC.L have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for AZN and BARC.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer